This finding has been confirmed by Hong et al.49, who examined the mRNA levels of BDNF and the mitogen-activated protein kinase 1/2 (MEK1/2), an immediate activator of the MEK–ERK pathway mediated by BDNF, in the leukocytes of MDD patients and healthy controls. This evidence concerns the gene MAP2K1 and major depressive disorder.